Trial Information

Official Title: Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant: an Open-labelled, Prospective Study

Summary

The purpose of this study is to evaluate changes in left ventricular mass and cardiac function in patients with active acromegaly before and after treatment with the growth hormone receptor antagonist pegvisomant for one year.

Phase: Phase 4

Sponsor: University of Wuerzburg

Overall Contacts:

Gwendolyn Bender, MD
004993120139716
bender_g@medizin.uni-wuerzburg.de

Bruno Allolio, MD
Phone: 004993120139020
allolio_b@medizin.uni-wuerzburg.de